Cancer Epigenome

Advances in Genetics

Volumn 70, Issue C, 2010, Pages 247-276

  Lechner, Matthias ^a   Boshoff, Chris ^a   Beck, Stephan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; MICRORNA; CHROMATIN;

ANIMAL; BOOK; CHROMATIN; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; GENOME; HUMAN; HUMAN GENOME; MALE; METABOLISM; NEOPLASM; TUMOR SUPPRESSOR GENE;

ANIMALS; CHROMATIN; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GENOME; GENOME, HUMAN; HISTONES; HUMANS; MALE; MICRORNAS; NEOPLASMS;

EID: 77957328477     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380866-0.60009-5     Document Type: Book

References (124)

1. Arai E., Ushijima S., Gotoh M., Ojima H., Kosuge T., Hosoda F., Shibata T., Kondo T., Yokoi S., Imoto I., Inazawa J., Hirohashi S., et al. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int. J. Cancer 2009, 125:2854-2862.
2. Bamford S., Dawson E., Forbes S., Clements J., Pettett R., Dogan A., Flanagan A., Teague J., Futreal P.A., Stratton M.R., Wooster R. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br. J. Cancer 2004, 91:355-358.
3. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
4. Baylin S.B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2005, 2(Suppl. 1):S4-S11.
5. Baylin S.B., Ohm J.E. Epigenetic gene silencing in cancer-A mechanism for early oncogenic pathway addiction?. Nat. Rev. Cancer 2006, 6:107-116.
6. Beck S., Rakyan V.K. The methylome: Approaches for global DNA methylation profiling. Trends Genet. 2008, 24:231-237.
7. Beck S., Olek A., Walter J. From genomics to epigenomics: A loftier view of life. Nat. Biotechnol. 1999, 17:1144.
8. Bennett K.L., Hackanson B., Smith L.T., Morrison C.D., Lang J.C., Schuller D.E., Weber F., Eng C., Plass C. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res. 2007, 67:4657-4664.
9. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
10. ® assay. Epigenomics 2009, 1:177-200.
11. Boerno S.T., Grimm C., Lehrach H., Schweiger M.R. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics. Epigenomics 2010, 2:199-207.
12. Bormann Chung C.A., Boyd V.L., McKernan K.J., Fu Y., Monighetti C., Peckham H.E., Barker M. Whole methylome analysis by ultra-deep sequencing using two-base encoding. PLoS One 2010, 5:e9320.
13. Butcher L.M., Beck S. AutoMeDIP-seq: A high-throughput, whole genome, DNA methylation assay. Methods 2010, (in press).
14. Carette J.E., Pruszak J., Varadarajan M., Blomen V.A., Gokhale S., Camargo F.D., Wernig M., Jaenisch R., Brummelkamp T.R. Generation of iPSCs from cultured human malignant cells. Blood 2010, 115(20):4039-4042.
15. Carvalho A.L., Chuang A., Jiang W.W., Lee J., Begum S., Poeta L., Zhao M., Jeronimo C., Henrique R., Nayak C.S., Park H.L., Brait M.R., et al. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res. 2006, 66:9401-9407.
16. Carvalho A.L., Jeronimo C., Kim M.M., Henrique R., Zhang Z., Hoque M.O., Chang S., Brait M., Nayak C.S., Jiang W.W., Claybourne Q., Tokumaru Y., et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin. Cancer Res. 2008, 14:97-107.
17. Cheung H.H., Lee T.L., Davis A.J., Taft D.H., Rennert O.M., Chan W.Y. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br. J. Cancer 2010, 102:419-427.
18. Chow J.C., Yen Z., Ziesche S.M., Brown C.J. Silencing of the mammalian X chromosome. Annu. Rev. Genomics Hum. Genet. 2005, 6:69-92.
19. Clarke J., Wu H.C., Jayasinghe L., Patel A., Reid S., Bayley H. Continuous base identification for single-molecule nanopore DNA sequencing. Nat. Nanotechnol. 2009, 4:265-270.
20. Cokus S.J., Feng S., Zhang X., Chen Z., Merriman B., Haudenschild C.D., Pradhan S., Nelson S.F., Pellegrini M., Jacobsen S.E. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008, 452:215-219.
21. Conley B.A. Treatment of advanced head and neck cancer: What lessons have we learned?. J. Clin. Oncol. 2006, 24:1023-1025.
22. Cortez C.C., Jones P.A. Chromatin, cancer and drug therapies. Mutat. Res. 2008, 647:44-51.
23. Crockford G.P., Linger R., Hockley S., Dudakia D., Johnson L., Huddart R., Tucker K., Friedlander M., Phillips K.A., Hogg D., Jewett M.A., Lohynska R., et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum. Mol. Genet. 2006, 15:443-451.
24. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., Feinberg A.P. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science 2003, 299:1753-1755.
25. Davidsson J., Lilljebjorn H., Andersson A., Veerla S., Heldrup J., Behrendtz M., Fioretos T., Johansson B. The DNA methylome of pediatric acute lymphoblastic leukemia. Hum. Mol. Genet. 2009, 18:4054-4065.
26. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
27. Dikshit R.P., Gillio-Tos A., Brennan P., De Marco L., Fiano V., Martinez-Penuela J.M., Boffetta P., Merletti F. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 2007, 110:1745-1751.
28. Doi A., Park I.H., Wen B., Murakami P., Aryee M.J., Irizarry R., Herb B., Ladd-Acosta C., Rho J., Loewer S., Miller J., Schlaeger T., et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 2009, 41:1350-1353.
29. Down T.A., Rakyan V.K., Turner D.J., Flicek P., Li H., Kulesha E., Graf S., Johnson N., Herrero J., Tomazou E.M., Thorne N.P., Backdahl L., et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol. 2008, 26:779-885.
30. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., Westra W.H., Gillison M.L. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007, 356:1944-1956.
31. Eckhardt F., Lewin J., Cortese R., Rakyan V.K., Attwood J., Burger M., Burton J., Cox T.V., Davies R., Down T.A., Haefliger C., Horton R., et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 2006, 38:1378-1385.
32. Eid J., Fehr A., Gray J., Luong K., Lyle J., Otto G., Peluso P., Rank D., Baybayan P., Bettman B., Bibillo A., Bjornson K., et al. Real-time DNA sequencing from single polymerase molecules. Science 2009, 323:133-138.
33. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999, 340:745-750.
34. Estecio M.R., Youssef E.M., Rahal P., Fukuyama E.E., Gois-Filho J.F., Maniglia J.V., Goloni-Bertollo E.M., Issa J.P., Tajara E.H. LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene 2006, 25:5018-5026.
35. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., Forastiere A., Gillison M.L. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 2008, 100:261-269.
36. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92.
37. Feinberg A.P., Ohlsson R., Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 2006, 7:21-33.
38. Fernandez A.F., Esteller M. Viral epigenomes in human tumorigenesis. Oncogene 2010, 29:1405-1420.
39. Flanagan J.M., Cocciardi S., Waddell N., Johnstone C.N., Marsh A., Henderson S., Simpson P., da Silva L., Khanna K., Lakhani S., Boshoff C., Chenevix-Trench G. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am. J. Hum. Genet. 2010, 86:420-433.
40. Flicek P., Aken B.L., Ballester B., Beal K., Bragin E., Brent S., Chen Y., Clapham P., Coates G., Fairley S., Fitzgerald S., Fernandez-Banet J., et al. Ensembl's 10th year. Nucleic Acids Res. 2010, 38:D557-D562.
41. Franzmann E.J., Reategui E.P., Pedroso F., Pernas F.G., Karakullukcu B.M., Carraway K.L., Hamilton K., Singal R., Goodwin W.J. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1348-1355.
42. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 1992, 89:1827-1831.
43. Gal-Yam E.N., Egger G., Iniguez L., Holster H., Einarsson S., Zhang X., Lin J.C., Liang G., Jones P.A., Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl. Acad. Sci. USA 2008, 105:12979-12984.
44. Gondor A., Ohlsson R. Chromosome crosstalk in three dimensions. Nature 2009, 461:212-217.
45. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
46. Grutzmann R., Molnar B., Pilarsky C., Habermann J.K., Schlag P.M., Saeger H.D., Miehlke S., Stolz T., Model F., Roblick U.J., Bruch H.P., Koch R., et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008, 3:e3759.
47. Harris T.D., Buzby P.R., Babcock H., Beer E., Bowers J., Braslavsky I., Causey M., Colonell J., Dimeo J., Efcavitch J.W., Giladi E., Gill J., et al. Single-molecule DNA sequencing of a viral genome. Science 2008, 320:106-109.
48. Hess C.J., Ameziane N., Schuurhuis G.J., Errami A., Denkers F., Kaspers G.J., Cloos J., Joenje H., Reinhardt D., Ossenkoppele G.J., Zwaan C.M., Waisfisz Q. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia. Cell Oncol. 2008, 30:299-306.
49. Hodges E., Smith A.D., Kendall J., Xuan Z., Ravi K., Rooks M., Zhang M.Q., Ye K., Bhattacharjee A., Brizuela L., McCombie W.R., Wigler M., et al. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res. 2009, 19:1593-1605.
50. Howell P.M., Liu S., Ren S., Behlen C., Fodstad O., Riker A.I. Epigenetics in human melanoma. Cancer Control 2009, 16:200-218.
51. Hsiung D.T., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., Kelsey K.T. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:108-114.
52. Huang Y., Pastor W.A., Shen Y., Tahiliani M., Liu D.R., Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010, 5:e8888.
53. Hunter K.D., Parkinson E.K., Harrison P.R. Profiling early head and neck cancer. Nat. Rev. Cancer 2005, 5:127-135.
54. International Cancer Genome Consortium International network of cancer genome projects. Nature 2010, 464:993-998.
55. Irizarry R.A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., Cui H., Gabo K., Rongione M., Webster M., Ji H., Potash J.B., et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet 2009, 41:178-186.
56. Issa J.P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 2004, 4:988-993.
57. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., Thun M.J. Cancer statistics, 2005. CA Cancer J. Clin. 2005, 55:10-30.
58. Johnson D.S., Mortazavi A., Myers R.M., Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502.
59. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
60. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 1999, 21:163-167.
61. Jones A., Lechner M., Fourkala E.O., Kristeleit R., Widschwendter M. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers. Epigenomics 2010, 2:9-38.
62. Killian J.K., Bilke S., Davis S., Walker R.L., Killian M.S., Jaeger E.B., Chen Y., Hipp J., Pittaluga S., Raffeld M., Cornelison R., Smith W.I., et al. Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res. 2009, 69:758-764.
63. Kim D.H., Nelson H.H., Wiencke J.K., Zheng S., Christiani D.C., Wain J.C., Mark E.J., Kelsey K.T. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 2001, 61:3419-3424.
64. Kim M.S., Lee J., Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010, 29:181-206.
65. Koga Y., Pelizzola M., Cheng E., Krauthammer M., Sznol M., Ariyan S., Narayan D., Molinaro A.M., Halaban R., Weissman S.M. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res. 2009, 19:1462-1470.
66. Laird P.W. Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 2010, 11:191-203.
67. Laurent L., Wong E., Li G., Huynh T., Tsirigos A., Ong C.T., Low H.M., Kin Sung K.W., Rigoutsos I., Loring J., Wei C.L. Dynamic changes in the human methylome during differentiation. Genome Res. 2010, 20:320-331.
68. Li N., Ye M., Li Y., Yan Z., Butcher L.M., Sun J., Han X., Chen Q., Zhang X., Wang J. Whole genome DNA Methylation analysis based on high throughput sequencing technology. Methods 2010, (in press).
69. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
70. Llovet J.M., Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003, 37:429-442.
71. Lo P.K., Sukumar S. Epigenomics and breast cancer. Pharmacogenomics 2008, 9:1879-1902.
72. Long C., Yin B., Lu Q., Zhou X., Hu J., Yang Y., Yu F., Yuan Y. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Cancer Invest. 2007, 25:685-690.
73. Manecksha R.P., Fitzpatrick J.M. Epidemiology of testicular cancer. BJU Int. 2009, 104:1329-1333.
74. Marsit C.J., Liu M., Nelson H.H., Posner M., Suzuki M., Kelsey K.T. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival. Oncogene 2004, 23:1000-1004.
75. Marsit C.J., Houseman E.A., Christensen B.C., Eddy K., Bueno R., Sugarbaker D.J., Nelson H.H., Karagas M.R., Kelsey K.T. Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res. 2006, 66:10621-10629.
76. Marsit C.J., Christensen B.C., Houseman E.A., Karagas M.R., Wrensch M.R., Yeh R.F., Nelson H.H., Wiemels J.L., Zheng S., Posner M.R., McClean M.D., Wiencke J.K., et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 2009, 30:416-422.
77. Martens J.W., Margossian A.L., Schmitt M., Foekens J., Harbeck N. DNA methylation as a biomarker in breast cancer. Future Oncol. 2009, 5:1245-1256.
78. Martone T., Gillio-Tos A., De Marco L., Fiano V., Maule M., Cavalot A., Garzaro M., Merletti F., Cortesina G. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin. Cancer Res. 2007, 13:5089-5094.
79. Matsubayashi H., Sato N., Fukushima N., Yeo C.J., Walter K.M., Brune K., Sahin F., Hruban R.H., Goggins M. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin. Cancer Res. 2003, 9:1446-1452.
80. McLendon R., Friedman A., Bigner D., Van Meir E.G., Brat D.J., Mastrogianakis G.M., Olson J.J., Mikkelsen T., Lehman N., Aldape K., Alfred Yung W.K., Bogler O., et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
81. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., Lee W., Mendenhall E., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
82. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
83. Morison I.M., Ramsay J.P., Spencer H.G. A census of mammalian imprinting. Trends Genet. 2005, 21:457-465.
84. Nayak C.S., Carvalho A.L., Jeronimo C., Henrique R., Kim M.M., Hoque M.O., Chang S., Jiang W.W., Koch W., Westra W., Sidransky D., Califano J. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Laryngoscope 2007, 117:1376-1380.
85. Noushmehr H., Weisenberger D.J., Diefes K., Phillips H.S., Pujara K., Berman B.P., Pan F., Pelloski C.E., Sulman E.P., Bhat K.P., Verhaak R.G., Hoadley K.A., et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010, 17(5):510-522.
86. Ogawa O., Eccles M.R., Szeto J., McNoe L.A., Yun K., Maw M.A., Smith P.J., Reeve A.E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993, 362:749-751.
87. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., Berman D.M., Jenuwein T., et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 2007, 39:237-242.
88. Park P.J. ChIP-seq: Advantages and challenges of a maturing technology. Nat. Rev. Genet. 2009, 10:669-680.
89. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
90. Pollard S.M., Stricker S.H., Beck S. A shore sign of reprogramming. Cell Stem Cell 2009, 5:571-572.
91. Rakyan V.K., Hildmann T., Novik K.L., Lewin J., Tost J., Cox A.V., Andrews T.D., Howe K.L., Otto T., Olek A., Fischer J., Gut I.G., et al. DNA methylation profiling of the human major histocompatibility complex: A pilot study for the human epigenome project. PLoS Biol. 2004, 2:e405.
92. Rakyan V.K., Down T.A., Thorne N.P., Flicek P., Kulesha E., Graf S., Tomazou E.M., Backdahl L., Johnson N., Herberth M., Howe K.L., Jackson D.K., et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008, 18:1518-1529.
93. Rakyan V.K., Down T.A., Maslau S., Andrew T., Yang T.P., Beyan H., Whittaker P., McCann O.T., Finer S., Valdes A.M., Leslie R.D., Deloukas P., et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 2010, 20:434-439.
94. Redaelli A., Laskin B.L., Stephens J.M., Botteman M.F., Pashos C.L. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur. J. Cancer Care (Engl.) 2005, 14:53-62.
95. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432.
96. Reinders J., Paszkowski J. Bisulfite methylation profiling of large genomes. Epigenomics 2010, 2:209-220.
97. Richards K.L., Zhang B., Baggerly K.A., Colella S., Lang J.C., Schuller D.E., Krahe R. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 2009, 4:e4941.
98. Righini C.A., de Fraipont F., Timsit J.F., Faure C., Brambilla E., Reyt E., Favrot M.C. Tumor-specific methylation in saliva: A promising biomarker for early detection of head and neck cancer recurrence. Clin. Cancer Res. 2007, 13:1179-1185.
99. Rodriguez T., Altieri A., Chatenoud L., Gallus S., Bosetti C., Negri E., Franceschi S., Levi F., Talamini R., La Vecchia C. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol. 2004, 40:207-213.
100. Rodriguez J., Munoz M., Vives L., Frangou C.G., Groudine M., Peinado M.A. Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc. Natl. Acad. Sci. USA 2008, 105:19809-19814.
101. Santarius T., Shipley J., Brewer D., Stratton M.R., Cooper C.S. A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 2010, 10:59-64.
102. Sawyers C.L. The cancer biomarker problem. Nature 2008, 452:548-552.
103. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., Bergman Y., Simon I., et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 2007, 39:232-236.
104. Sengupta S., Chakrabarti S., Roy A., Panda C.K., Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007, 109:703-712.
105. Sladden M.J., Balch C., Barzilai D.A., Berg D., Freiman A., Handiside T., Hollis S., Lens M.B., Thompson J.F. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst. Rev. 2009, (4). CD004835.
106. Smith L.T., Lin M., Brena R.M., Lang J.C., Schuller D.E., Otterson G.A., Morrison C.D., Smiraglia D.J., Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc. Natl. Acad. Sci. USA 2006, 103:982-987.
107. Steinmann K., Sandner A., Schagdarsurengin U., Dammann R.H. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol. Rep. 2009, 22:1519-1526.
108. Subbalekha K., Pimkhaokham A., Pavasant P., Chindavijak S., Phokaew C., Shuangshoti S., Matangkasombut O., Mutirangura A. Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients. Oral Oncol. 2009, 45:184-191.
109. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Chen W.D., Pretlow T.P., Yang B., Akiyama Y., Van Engeland M., Toyota M., Tokino T., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 2004, 36:417-422.
110. Taylor K.H., Kramer R.S., Davis J.W., Guo J., Duff D.J., Xu D., Caldwell C.W., Shi H. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 2007, 67:8511-8518.
111. Teschendorff A.E., Menon U., Gentry-Maharaj A., Ramus S.J., Gayther S.A., Apostolidou S., Jones A., Lechner M., Beck S., Jacobs I.J., Widschwendter M. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 2009, 4:e8274.
112. Teschendorff A.E., Menon U., Gentry-Maharaj A., Ramus S.J., Weisenberger D.J., Shen H., Campan M., Noushmehr H., Bell C.G., Maxwell A.P., Savage D.A., Mueller-Holzner E., et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010, 20:440-446.
113. Tirino V., Desiderio V., d'Aquino R., De Francesco F., Pirozzi G., Graziano A., Galderisi U., Cavaliere C., De Rosa A., Papaccio G., Giordano A. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 2008, 3:e3469.
114. Tolstorukov M.Y., Kharchenko P.V., Park P.J. Analysis of the primary structure of chromatin with next-generation sequencing. Epigenomics 2010, 2:187-197.
115. Tommasi S., Karm D.L., Wu X., Yen Y., Pfeifer G.P. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res. 2009, 11:R14.
116. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 1999, 96:8681-8686.
117. Tran N., Rose B.R., O'Brien C.J. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck 2007, 29:64-70.
118. Veltri R.W., Makarov D.V. Nucleic acid-based marker approaches to urologic cancers. Urol. Oncol. 2006, 24:510-527.
119. Weber A., Hengge U.R., Bardenheuer W., Tischoff I., Sommerer F., Markwarth A., Dietz A., Wittekind C., Tannapfel A. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 2005, 24:6699-6708.
120. Wen B., Wu H., Shinkai Y., Irizarry R.A., Feinberg A.P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 2009, 41:246-250.
121. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., Weisenberger D.J., Campan M., Young J., Jacobs I., Laird P.W. Epigenetic stem cell signature in cancer. Nat. Genet. 2007, 39:157-158.
122. Wilson A.S., Power B.E., Molloy P.L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta 2007, 1775:138-162.
123. Zhang X., Yazaki J., Sundaresan A., Cokus S., Chan S.W., Chen H., Henderson I.R., Shinn P., Pellegrini M., Jacobsen S.E., Ecker J.R. Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell 2006, 126:1189-1201.
124. Zilberman D., Gehring M., Tran R.K., Ballinger T., Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat. Genet. 2007, 39:61-69.